(-)-gambogic acid decreases expression ISO RGD:732407 6480464 gambogic acid results in decreased expression of AKT2 mRNA CTD PMID:33533530 (1->4)-beta-D-glucan multiple interactions ISO RGD:10132 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AKT2 mRNA CTD PMID:36331819 (S)-nicotine affects expression EXP 6480464 Nicotine affects the expression of AKT2 mRNA CTD PMID:31972234 (S)-nicotine increases expression ISO RGD:10132 6480464 Nicotine results in increased expression of AKT2 mRNA CTD PMID:31945395 1,2-dichloroethane increases expression ISO RGD:10132 6480464 ethylene dichloride results in increased expression of AKT2 mRNA CTD PMID:28189721 , PMID:28960355 1,2-dimethylhydrazine decreases expression EXP 6480464 1, 2-Dimethylhydrazine results in decreased expression of AKT2 mRNA CTD PMID:32387197 1,2-dimethylhydrazine increases expression ISO RGD:10132 6480464 1, 2-Dimethylhydrazine results in increased expression of AKT2 mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO RGD:732407 6480464 Dinitrochlorobenzene binds to AKT2 protein CTD PMID:32991956 17alpha-ethynylestradiol multiple interactions ISO RGD:10132 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AKT2 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:732407 6480464 Estradiol affects the expression of AKT2 mRNA CTD PMID:22574217 2,2',4,4'-Tetrabromodiphenyl ether increases phosphorylation EXP 6480464 2 more ... CTD PMID:33581290 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:10132 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AKT2 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:10132 6480464 Tetrachlorodibenzodioxin results in increased expression of AKT2 mRNA CTD PMID:15328365 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:10132 6480464 Tetrachlorodibenzodioxin results in decreased expression of AKT2 mRNA CTD PMID:19465110 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of AKT2 mRNA CTD PMID:19643169 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of AKT2 mRNA CTD PMID:19643169 , PMID:21061450 2-nitrotoluene increases expression EXP 6480464 2-nitrotoluene results in increased expression of AKT2 mRNA CTD PMID:16460773 4,4'-sulfonyldiphenol decreases expression EXP 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of AKT2 mRNA CTD PMID:26186136 4,4'-sulfonyldiphenol increases expression ISO RGD:732407 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of AKT2 protein CTD PMID:34186270 4-nonylphenol increases expression EXP 6480464 4-nonylphenol results in increased expression of AKT2 mRNA CTD PMID:30228064 4-vinylcyclohexene dioxide increases expression ISO RGD:10132 6480464 4-vinyl-1-cyclohexene dioxide results in increased expression of AKT2 mRNA CTD PMID:20829426 5-fluorouracil increases expression ISO RGD:732407 6480464 Fluorouracil results in increased expression of AKT2 protein CTD PMID:16803524 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of AKT2 mRNA CTD PMID:31881176 acetylsalicylic acid increases expression ISO RGD:732407 6480464 Aspirin results in increased expression of AKT2 mRNA CTD PMID:11906190 acrolein multiple interactions ISO RGD:732407 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of AKT2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of AKT2 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of AKT2 mRNA CTD PMID:31644924 afimoxifene decreases response to substance ISO RGD:732407 6480464 AKT2 protein results in decreased susceptibility to afimoxifene CTD PMID:18351453 aldehydo-D-glucose affects response to substance ISO RGD:10132 6480464 AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 all-trans-retinoic acid multiple interactions EXP 6480464 [nitrofen co-treated with Tretinoin] results in increased expression of AKT2 mRNA CTD PMID:20623292 alpha-pinene multiple interactions ISO RGD:732407 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of AKT2 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which affects the expression of AKT2 mRNA CTD PMID:32699268 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:10132 6480464 [TNFSF11 protein co-treated with pyrazolanthrone] results in increased expression of AKT2 mRNA, crocin inhibits the reaction [[TNFSF11 protein co-treated with pyrazolanthrone] results in increased expression of AKT2 mRNA] CTD PMID:30580027 antirheumatic drug increases expression ISO RGD:732407 6480464 Antirheumatic Agents results in increased expression of AKT2 mRNA CTD PMID:24449571 arsenite(3-) increases expression ISO RGD:732407 6480464 arsenite results in increased expression of AKT2 mRNA CTD PMID:34425169 arsenous acid decreases response to substance ISO RGD:732407 6480464 AKT2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:18048359 benzo[a]pyrene decreases methylation ISO RGD:732407 6480464 Benzo(a)pyrene results in decreased methylation of AKT2 5' UTR CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:10132 6480464 thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of AKT2 protein] CTD PMID:36193556 benzo[a]pyrene increases phosphorylation ISO RGD:10132 6480464 Benzo(a)pyrene results in increased phosphorylation of AKT2 protein CTD PMID:36193556 Benzo[k]fluoranthene decreases expression ISO RGD:732407 6480464 benzo(k)fluoranthene results in decreased expression of AKT2 mRNA CTD PMID:21635667 berberine multiple interactions ISO RGD:10132 6480464 Berberine inhibits the reaction [Dexamethasone results in decreased expression of AKT2 mRNA] CTD PMID:20462044 Bergenin multiple interactions ISO RGD:10132 6480464 bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in increased expression of AKT2 mRNA] CTD PMID:31369791 bis(2-chloroethyl) sulfide increases expression ISO RGD:10132 6480464 Mustard Gas results in increased expression of AKT2 mRNA CTD PMID:18955075 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of AKT2 mRNA CTD PMID:25280772 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of AKT2 mRNA CTD PMID:25181051 more ... bisphenol A decreases expression ISO RGD:732407 6480464 bisphenol A results in decreased expression of AKT2 protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:732407 6480464 bisphenol A results in decreased methylation of AKT2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:732407 6480464 bisphenol A results in increased expression of AKT2 mRNA CTD PMID:33670352 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of AKT2 mRNA, bisphenol A results in increased expression of AKT2 protein CTD PMID:24884420 , PMID:27539358 Bisphenol B increases phosphorylation EXP 6480464 bisphenol B results in increased phosphorylation of AKT2 protein CTD PMID:33940105 Bisphenol B increases expression ISO RGD:732407 6480464 bisphenol B results in increased expression of AKT2 protein CTD PMID:34186270 bisphenol F increases expression ISO RGD:10132 6480464 bisphenol F results in increased expression of AKT2 mRNA CTD PMID:34147605 bromochloroacetic acid increases expression EXP 6480464 bromochloroacetic acid results in increased expression of AKT2 mRNA CTD PMID:16460773 butanal decreases expression ISO RGD:732407 6480464 butyraldehyde results in decreased expression of AKT2 mRNA CTD PMID:26079696 Butylbenzyl phthalate increases phosphorylation EXP 6480464 butylbenzyl phthalate results in increased phosphorylation of AKT2 protein CTD PMID:31319113 butyric acid multiple interactions EXP 6480464 Butyric Acid inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased phosphorylation of AKT2 protein] CTD PMID:27270450 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of AKT2 mRNA CTD PMID:19167457 cadmium dichloride affects expression ISO RGD:10132 6480464 Cadmium Chloride affects the expression of AKT2 mRNA CTD PMID:18974090 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of AKT2 mRNA CTD PMID:33453195 caffeine affects phosphorylation ISO RGD:732407 6480464 Caffeine affects the phosphorylation of AKT2 protein CTD PMID:35688186 cannabidiol multiple interactions ISO RGD:732407 6480464 [Oxygen co-treated with Ozone co-treated with Cannabidiol] results in decreased expression of AKT2 mRNA CTD PMID:32992648 carbamazepine affects expression ISO RGD:732407 6480464 Carbamazepine affects the expression of AKT2 mRNA CTD PMID:24752500 carbon nanotube increases expression ISO RGD:10132 6480464 Nanotubes, Carbon analog results in increased expression of AKT2 mRNA CTD PMID:25554681 carmustine decreases expression ISO RGD:732407 6480464 Carmustine results in decreased expression of AKT2 mRNA CTD PMID:15980968 chlorpyrifos decreases phosphorylation ISO RGD:732407 6480464 Chlorpyrifos results in decreased phosphorylation of AKT2 protein CTD PMID:23994500 cisplatin increases expression ISO RGD:732407 6480464 Cisplatin results in increased expression of AKT2 protein CTD PMID:16803524 clenbuterol multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] CTD PMID:16339297 clozapine increases expression EXP 6480464 Clozapine results in increased expression of AKT2 mRNA CTD PMID:15860345 colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] CTD PMID:16339297 copper atom decreases expression ISO RGD:732407 6480464 Copper results in decreased expression of AKT2 protein CTD PMID:22692975 copper atom multiple interactions ISO RGD:732407 6480464 [Chelating Agents binds to Copper] which results in decreased expression of AKT2 mRNA CTD PMID:30911355 copper(0) decreases expression ISO RGD:732407 6480464 Copper results in decreased expression of AKT2 protein CTD PMID:22692975 copper(0) multiple interactions ISO RGD:732407 6480464 [Chelating Agents binds to Copper] which results in decreased expression of AKT2 mRNA CTD PMID:30911355 cortisol decreases expression ISO RGD:732407 6480464 Hydrocortisone results in decreased expression of AKT2 mRNA CTD PMID:31075344 , PMID:32535229 crocin-1 multiple interactions ISO RGD:10132 6480464 crocin inhibits the reaction [[TNFSF11 protein co-treated with pyrazolanthrone] results in increased expression of AKT2 mRNA] CTD PMID:30580027 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of AKT2 mRNA CTD PMID:26577399 curcumin multiple interactions ISO RGD:732407 6480464 Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form], Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein] CTD PMID:23452621 curcumin decreases expression ISO RGD:732407 6480464 Curcumin analog results in decreased expression of AKT2 mRNA CTD PMID:26409325 D-glucose affects response to substance ISO RGD:10132 6480464 AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of AKT2 mRNA CTD PMID:23914054 dexamethasone multiple interactions ISO RGD:10132 6480464 Berberine inhibits the reaction [Dexamethasone results in decreased expression of AKT2 mRNA] CTD PMID:20462044 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of AKT2 mRNA CTD PMID:35148621 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [SMAD5 protein binds to AKT2 gene] CTD PMID:20079400 dexamethasone decreases expression ISO RGD:10132 6480464 Dexamethasone results in decreased expression of AKT2 mRNA CTD PMID:20462044 diarsenic trioxide decreases response to substance ISO RGD:732407 6480464 AKT2 protein results in decreased susceptibility to Arsenic Trioxide CTD PMID:18048359 diazinon affects expression EXP 6480464 Diazinon affects the expression of AKT2 mRNA CTD PMID:22546817 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in decreased expression of AKT2 mRNA CTD PMID:18636392 diclofenac affects expression ISO RGD:732407 6480464 Diclofenac affects the expression of AKT2 mRNA CTD PMID:24752500 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of AKT2 mRNA CTD PMID:22546817 dimethoate decreases phosphorylation ISO RGD:732407 6480464 Dimethoate results in decreased phosphorylation of AKT2 protein CTD PMID:23994500 dioxygen multiple interactions ISO RGD:732407 6480464 3 more ... CTD PMID:23452621 , PMID:32992648 dioxygen increases expression ISO RGD:732407 6480464 Oxygen deficiency results in increased expression of AKT2 protein, Oxygen deficiency results in increased expression of AKT2 protein modified form CTD PMID:23452621 dobutamine multiple interactions EXP 6480464 Dobutamine inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] CTD PMID:16339297 dorsomorphin multiple interactions ISO RGD:732407 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AKT2 mRNA CTD PMID:27188386 doxorubicin affects response to substance ISO RGD:732407 6480464 AKT2 protein affects the susceptibility to Doxorubicin CTD PMID:18071906 doxorubicin multiple interactions ISO RGD:732407 6480464 [Doxorubicin co-treated with resveratrol] affects the expression of AKT2 mRNA CTD PMID:26969377 doxorubicin affects expression ISO RGD:732407 6480464 Doxorubicin affects the expression of AKT2 mRNA CTD PMID:26969377 epoxiconazole decreases expression ISO RGD:10132 6480464 epoxiconazole results in decreased expression of AKT2 mRNA CTD PMID:35436446 ethanol affects expression EXP 6480464 Ethanol affects the expression of AKT2 mRNA CTD PMID:31039417 , PMID:31075344 ethanol increases expression EXP 6480464 Ethanol results in increased expression of AKT2 mRNA CTD PMID:32535229 ethanol affects splicing ISO RGD:10132 6480464 Ethanol affects the splicing of AKT2 mRNA CTD PMID:30319688 finasteride increases expression EXP 6480464 Finasteride results in increased expression of AKT2 mRNA CTD PMID:24136188 flutamide increases expression EXP 6480464 Flutamide results in increased expression of AKT2 mRNA CTD PMID:24136188 genistein decreases expression ISO RGD:732407 6480464 Genistein results in decreased expression of AKT2 mRNA CTD PMID:15257099 genistein multiple interactions ISO RGD:732407 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein modified form], Genistein inhibits the reaction [Oxygen deficiency results in increased expression of AKT2 protein] CTD PMID:23452621 genistein decreases expression ISO RGD:10132 6480464 Genistein results in decreased expression of AKT2 mRNA CTD PMID:24967385 glucose affects response to substance ISO RGD:10132 6480464 AKT2 protein affects the susceptibility to Glucose CTD PMID:21964073 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of AKT2 mRNA CTD PMID:15860345 hexachlorobenzene multiple interactions EXP 6480464 [Hexachlorobenzene co-treated with Methylnitrosourea] results in increased phosphorylation of AKT2 protein CTD PMID:22245120 hydralazine multiple interactions ISO RGD:732407 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of AKT2 mRNA CTD PMID:17183730 hydrogen cyanide decreases expression ISO RGD:10132 6480464 Hydrogen Cyanide results in decreased expression of AKT2 mRNA CTD PMID:33914522 hydroquinone multiple interactions ISO RGD:10132 6480464 hydroquinone inhibits the reaction [AKT2 protein results in increased phosphorylation of IRF3 protein] CTD PMID:28883758 inulin multiple interactions ISO RGD:10132 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKT2 mRNA CTD PMID:36331819 L-ascorbic acid affects expression ISO RGD:732407 6480464 Ascorbic Acid affects the expression of AKT2 mRNA CTD PMID:30597948 lead diacetate increases expression ISO RGD:10132 6480464 lead acetate results in increased expression of AKT2 mRNA CTD PMID:22609695 , PMID:33932463 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of AKT2 mRNA CTD PMID:30980912 lead(0) decreases expression ISO RGD:732407 6480464 Lead results in decreased expression of AKT2 mRNA CTD PMID:19921347 lead(2+) decreases expression ISO RGD:732407 6480464 Lead results in decreased expression of AKT2 mRNA CTD PMID:19921347 losartan multiple interactions ISO RGD:10132 6480464 Losartan inhibits the reaction [AGT protein results in increased expression of AKT2 protein] CTD PMID:28578904 maleic acid decreases expression ISO RGD:732407 6480464 maleic acid results in decreased expression of AKT2 mRNA CTD PMID:28392987 mercury atom decreases expression ISO RGD:732407 6480464 Mercury results in decreased expression of AKT2 mRNA CTD PMID:16823088 mercury(0) decreases expression ISO RGD:732407 6480464 Mercury results in decreased expression of AKT2 mRNA CTD PMID:16823088 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in decreased phosphorylation of AKT2 protein] CTD PMID:27270450 methimazole decreases expression ISO RGD:10132 6480464 Methimazole results in decreased expression of AKT2 mRNA CTD PMID:29990518 methimazole decreases expression ISO RGD:732407 6480464 Methimazole results in decreased expression of AKT2 mRNA CTD PMID:29990518 methoxychlor increases expression ISO RGD:10132 6480464 Methoxychlor results in increased expression of AKT2 mRNA CTD PMID:20829426 methylglyoxal multiple interactions ISO RGD:10132 6480464 [TNFSF11 protein co-treated with Pyruvaldehyde] results in increased expression of AKT2 mRNA, bergenin inhibits the reaction [[TNFSF11 protein co-treated with Pyruvaldehyde] results in increased expression of AKT2 mRNA] CTD PMID:31369791 methylseleninic acid decreases expression ISO RGD:732407 6480464 methylselenic acid results in decreased expression of AKT2 mRNA CTD PMID:11830524 microcystin-LR increases expression ISO RGD:732407 6480464 cyanoginosin LR results in increased expression of AKT2 mRNA CTD PMID:27796937 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AKT2 gene CTD PMID:33148267 N-[3-(aminomethyl)benzyl]acetamidine affects response to substance ISO RGD:10132 6480464 AKT2 protein affects the susceptibility to N-(3-(aminomethyl)benzyl)acetamidine CTD PMID:21964073 N-methyl-N-nitrosourea multiple interactions EXP 6480464 [Hexachlorobenzene co-treated with Methylnitrosourea] results in increased phosphorylation of AKT2 protein CTD PMID:22245120 N-nitrosodiethylamine increases phosphorylation ISO RGD:10132 127285675 N-nitrosodiethylamine increases phosphorylation of Akt2 protein in liver RGD N-Vinyl-2-pyrrolidone multiple interactions EXP 6480464 [N-vinyl-2-pyrrolidinone binds to N-vinyl-2-pyrrolidinone] which results in increased expression of AKT2 mRNA CTD PMID:22037397 nickel atom decreases expression ISO RGD:732407 6480464 Nickel results in decreased expression of AKT2 mRNA CTD PMID:25583101 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of AKT2 mRNA CTD PMID:22546817 nicotine increases expression ISO RGD:10132 6480464 Nicotine results in increased expression of AKT2 mRNA CTD PMID:31945395 nicotine affects expression EXP 6480464 Nicotine affects the expression of AKT2 mRNA CTD PMID:31972234 nitenpyram decreases expression ISO RGD:732407 6480464 nitenpyram results in decreased expression of AKT2 mRNA CTD PMID:35568224 nitrofen multiple interactions EXP 6480464 [nitrofen co-treated with Tretinoin] results in increased expression of AKT2 mRNA CTD PMID:20623292 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of AKT2 mRNA CTD PMID:20152353 obeticholic acid decreases expression ISO RGD:732407 6480464 obeticholic acid results in decreased expression of AKT2 mRNA CTD PMID:27939613 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKT2 mRNA CTD PMID:25729387 oxidopamine multiple interactions EXP 6480464 Clenbuterol inhibits the reaction [Oxidopamine results in decreased phosphorylation of AKT2 protein] more ... CTD PMID:16339297 oxidopamine decreases phosphorylation EXP 6480464 Oxidopamine results in decreased phosphorylation of AKT2 protein CTD PMID:16339297 ozone multiple interactions EXP 6480464 [Coconut Oil co-treated with Ozone] results in decreased expression of AKT2 mRNA more ... CTD PMID:18636392 , PMID:33217375 ozone multiple interactions ISO RGD:732407 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of AKT2 mRNA more ... CTD PMID:32699268 , PMID:32992648 ozone decreases expression EXP 6480464 Ozone results in decreased expression of AKT2 mRNA CTD PMID:33217375 , PMID:33524448 p-menthan-3-ol decreases expression ISO RGD:732407 6480464 Menthol results in decreased expression of AKT2 mRNA CTD PMID:26760959 Pachymic acid multiple interactions ISO RGD:10132 6480464 pachymic acid analog inhibits the reaction [AGT protein results in increased expression of AKT2 protein] CTD PMID:28578904 paclitaxel affects response to substance ISO RGD:732407 6480464 AKT2 protein affects the susceptibility to Paclitaxel CTD PMID:18071906 paclitaxel increases phosphorylation ISO RGD:732407 6480464 Paclitaxel results in increased phosphorylation of AKT2 protein CTD PMID:18071906 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of AKT2 mRNA CTD PMID:33387578 paraquat multiple interactions ISO RGD:10132 6480464 AKT2 protein affects the reaction [Paraquat results in decreased expression of PPARGC1A protein], AKT2 protein affects the reaction [Paraquat results in increased expression of NFE2L2 protein] CTD PMID:28115273 paraquat increases response to substance ISO RGD:10132 6480464 AKT2 protein results in increased susceptibility to Paraquat CTD PMID:28115273 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorododecanoic acid decreases phosphorylation EXP 6480464 perfluorododecanoic acid results in decreased phosphorylation of AKT2 protein CTD PMID:30489073 perfluoroheptanoic acid increases phosphorylation EXP 6480464 perfluoro-n-heptanoic acid results in increased phosphorylation of AKT2 protein CTD PMID:33220336 perfluorooctane-1-sulfonic acid decreases expression EXP 6480464 perfluorooctane sulfonic acid results in decreased expression of AKT2 protein modified form CTD PMID:28439067 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:10132 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of AKT2 mRNA, [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of AKT2 mRNA CTD PMID:36331819 perfluoroundecanoic acid decreases phosphorylation EXP 6480464 perfluoroundecanoic acid results in decreased phosphorylation of AKT2 protein CTD PMID:33549592 , PMID:35143807 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in decreased methylation of AKT2 gene CTD PMID:33148267 phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of AKT2 mRNA CTD PMID:22037397 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of AKT2 mRNA CTD PMID:19162173 propiconazole decreases expression ISO RGD:10132 6480464 propiconazole results in decreased expression of AKT2 mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:732407 6480464 Quercetin results in decreased expression of AKT2 mRNA CTD PMID:30152185 quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT2 mRNA] CTD PMID:33038355 resveratrol multiple interactions ISO RGD:732407 6480464 [Doxorubicin co-treated with resveratrol] affects the expression of AKT2 mRNA more ... CTD PMID:23452621 , PMID:26969377 resveratrol decreases expression ISO RGD:732407 6480464 resveratrol results in decreased expression of AKT2 mRNA CTD PMID:26969377 SB 431542 multiple interactions ISO RGD:732407 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of AKT2 mRNA CTD PMID:27188386 silicon dioxide increases expression ISO RGD:732407 6480464 Silicon Dioxide analog results in increased expression of AKT2 mRNA CTD PMID:23806026 sirolimus multiple interactions ISO RGD:732407 6480464 [Sirolimus results in increased activity of AKT2 protein] which results in increased expression of CALD1 protein more ... CTD PMID:17908691 sodium arsenite decreases methylation ISO RGD:732407 6480464 sodium arsenite results in decreased methylation of AKT2 gene CTD PMID:25199682 sodium arsenite multiple interactions ISO RGD:10132 6480464 SEMA3A protein inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein], SEMA4A protein promotes the reaction [sodium arsenite results in increased phosphorylation of AKT2 protein] CTD PMID:33290778 sodium arsenite increases phosphorylation ISO RGD:10132 6480464 sodium arsenite results in increased phosphorylation of AKT2 protein CTD PMID:33290778 sodium tungstate affects expression ISO RGD:732407 6480464 sodium tungstate(VI) affects the expression of AKT2 mRNA CTD PMID:26164860 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in decreased phosphorylation of AKT2 protein more ... CTD PMID:27270450 sulindac decreases expression ISO RGD:732407 6480464 Sulindac results in decreased expression of AKT2 mRNA CTD PMID:11906190 sulindac increases expression EXP 6480464 Sulindac results in increased expression of AKT2 mRNA CTD PMID:24136188 tert-butyl hydroperoxide decreases expression ISO RGD:732407 6480464 tert-Butylhydroperoxide results in decreased expression of AKT2 mRNA CTD PMID:27509014 tert-butyl hydroperoxide increases methylation ISO RGD:732407 6480464 tert-Butylhydroperoxide results in increased methylation of AKT2 gene CTD PMID:27509014 testosterone increases expression ISO RGD:732407 6480464 Testosterone results in increased expression of AKT2 mRNA CTD PMID:21880219 thymoquinone multiple interactions ISO RGD:10132 6480464 thymoquinone inhibits the reaction [Benzo(a)pyrene results in increased phosphorylation of AKT2 protein] CTD PMID:36193556 titanium dioxide increases expression ISO RGD:10132 6480464 titanium dioxide results in increased expression of AKT2 mRNA CTD PMID:29128614 , PMID:29264374 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of AKT2 mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of AKT2 mRNA CTD PMID:25729387 torcetrapib increases expression ISO RGD:732407 6480464 torcetrapib results in increased expression of AKT2 mRNA CTD PMID:23228038 triciribine decreases phosphorylation ISO RGD:732407 6480464 triciribine results in decreased phosphorylation of AKT2 protein CTD PMID:20857426 triphenylstannane multiple interactions EXP 6480464 [triphenyltin co-treated with ethylene dimethanesulfonate] affects the phosphorylation of AKT2 protein CTD PMID:30772500 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of AKT2 mRNA CTD PMID:23639586 valproic acid multiple interactions ISO RGD:732407 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of AKT2 mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid decreases expression ISO RGD:10132 6480464 Valproic Acid results in decreased expression of AKT2 mRNA CTD PMID:32445665 valproic acid decreases expression ISO RGD:732407 6480464 Valproic Acid results in decreased expression of AKT2 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:732407 6480464 Valproic Acid affects the expression of AKT2 mRNA CTD PMID:25979313 vincristine decreases expression EXP 6480464 Vincristine results in decreased expression of AKT2 mRNA CTD PMID:33038355 vincristine multiple interactions EXP 6480464 Quercetin inhibits the reaction [Vincristine results in decreased expression of AKT2 mRNA] CTD PMID:33038355 xanthohumol multiple interactions ISO RGD:10132 6480464 xanthohumol inhibits the reaction [TNFSF11 protein results in increased expression of AKT2 mRNA] CTD PMID:23994090 xanthohumol decreases phosphorylation ISO RGD:732407 6480464 xanthohumol results in decreased phosphorylation of AKT2 protein CTD PMID:35229981 zinc atom increases expression EXP 6480464 Zinc deficiency results in increased expression of AKT2 mRNA CTD PMID:19111725 zinc(0) increases expression EXP 6480464 Zinc deficiency results in increased expression of AKT2 mRNA CTD PMID:19111725